The present and future of precision medicine in psychiatry: Focus on clinical psychopharmacology of antidepressants

Clinical Psychopharmacology and Neuroscience

Volumn 16, Issue 1, 2018, Pages 1-6

  Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antidepressive agents; Depression; Precision medicine; Psychiatry; Psychopharmacology

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SERTRALINE; VENLAFAXINE; VORTIOXETINE;

COMORBIDITY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FUTUROLOGY; HUMAN; MENTAL DISEASE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRY; PSYCHOPHARMACOLOGY; REVIEW; SYMPTOMATOLOGY;

EID: 85041674305     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2018.16.1.1     Document Type: Review

References (17)

1. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010;71:1259-1272.
2. Alberti S, Chiesa A, Andrisano C, Serretti A. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a metaanalysis. J Clin Psychopharmacol 2015;35:296-303.
3. Delavenne X, Magnin M, Basset T, Piot M, Mallouk N, Ressnikoff D, et al. Investigation of drug-drug interactions between clopidogrel and fluoxetine. Fundam Clin Pharmacol 2013;27:683-689.
4. Fabbri C, Crisafulli C, Calabrò M, Spina E, Serretti A. Progress and prospects in pharmacogenetics of antidepressant drugs. Expert Opin Drug Metab Toxicol 2016;12:1157-1168.
5. Perlis RH. Abandoning personalization to get to precision in the pharmacotherapy of depression. World Psychiatry 2016; 15:228-235.
6. Sankar PL, Parker LS. The Precision Medicine Initiative's All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genet Med 2017;19:743-750.
7. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Can J Psychiatry 2016;61:540-560.
8. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373:746-758.
9. Franchini L, Serretti A, Gasperini M, Smeraldi E. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 1998;32:255-259.
10. Porcelli S, Fabbri C, Spina E, Serretti A, De Ronchi D. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism. Expert Opin Drug Metab Toxicol 2011;7:1101-1115.
11. Stahl SM. Stahl's essential psychopharmacology: neuroscientific basis and practical application. New York: Cambridge University Press;2013.
12. Serretti A, Calati R, Goracci A, Di Simplicio M, Castrogiovanni P, De Ronchi D. Antidepressants in healthy subjects: what are the psychotropic/psychological effects? Eur Neuropsychopharmacol 2010;20:433-453.
13. Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry 2017;4:409-418.
14. Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in psychiatry. 12th ed. London:John Wiley & Sons;2015.
15. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 2009;29:259-266.
16. Jeon SW, Han C, Ko YH, Yoon SY, Pae CU, Choi J, et al. Measurement-based treatment of residual symptoms using clinically useful depression outcome scale: Korean validation study. Clin Psychopharmacol Neurosci 2017;15:28-34.
17. Oh KS, Shin E, Ha J, Shin D, Shin Y, Lim SW. Early improvement in one week predicts the treatment response to escitalopram in patients with social anxiety disorder: a preliminary study. Clin Psychopharmacol Neurosci 2016;14:161-167.